We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more OK

Roche Menu Search Global Web Site : Products

Ban katantaYou are here:

Products
Product list

Roche Language: DE

Home
About Roche
Sustainability
Research & Development
Partnering
Media
Investors
Careers
Products

Pharmaceuticals
Solutions for Diagnostics
Products for Researchers

Roche - Product list

A

Actemra/RoActemra (tocilizumab)
Alecensa (alectinib)
Avastin (bevacizumab)

C

CellCept (mycophenolate mofetil)
Copegus (ribavarin)
Cotellic (cobimetinib)

E

Enspryng (satralizumab)
Erivedge (vismodegib)
Esbriet (pirfenidone)
Evrysdi (risdiplam)

F

Fuzeon (enfuvirtide)

G

Gazyva/Gazyvaro (obinutuzumab)

H

Hemlibra (emicizumab)
Herceptin (trastuzumab)
Herceptin SC / Herceptin Hylecta (trastuzumab hyaluronidase)

I

Invirase (saquinavir)

K

Kadcyla (trastuzumab emtansine)

M

MabThera / Rituxan (rituximab)
MabThera SC / Rituxan Hycela (rituximab hyaluronidase)
Madopar (levodopa benserazide)
Mircera (methoxy polyethylene glycol epoetin beta)

N

NeoRecormon (epoetin beta)

O

Ocrevus (ocrelizumab)

P

Pegasys (peginterferon α)
Perjeta (pertuzumab)
Phesgo (pertuzumab trastuzumab hyaluronidase)
Polivy (polatuzumab vedotin)
Pulmozyme (dornase alfa)

R

Rivotril (clonazepam)
Roaccutane/Accutane (isotretinoin)
Rocephin (ceftriaxone)
Rozlytrek (entrectinib)

T

Tamiflu (oseltamivir)
Tarceva (erlotinib)
Tecentriq (atezolizumab)

V

Valcyte (valganciclovir)
Valium / Valrelease (diazepam)

X

Xeloda (capecitabine)
Xofluza (baloxavir marboxil)

Z

Zelboraf (vemurafenib)

Our global product portfolio

Products A-Z

Diseases

Products for Researchers

Ban katantaSolutions for Diagnostics

© 2020 F. Hoffmann-La Roche Ltd
27.11.2020

Legal Statement
Privacy Policy
Cookie Settings

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.